TCRX TScan Therapeutics, Inc. Common Stock BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

TScan Therapeutics (TCRX) Stock: Buy, Sell, or Hold?

$0.17
-0.01 (-6.36%) ▼
5d: -4.4% 30d: -17.47% 90d: -77.68%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (90%)
Quality Score
50/100
Position
OVERSOLD
30-Day Fair Range
$0.18 – $0.24
Position: OVERSOLD
Forward P/E & Valuation
-0.3x
Next 12M consensus est.
Wall Street Target
$1.00
+438.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.17 / $0.21
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: TCRX shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When TCRX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: TCRX is currently trading at $0.17, which is considered oversold relative to its 30-day fair value range of $0.18 to $0.24.

Technical Outlook: Technically, TCRX is in a strong downtrend. The price is currently testing key support at $0.17. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.4% recently.

Market Sentiment: TCRX scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $1.00 (+438.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $0.18 - $0.24
Company Quality Score 50/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 89.5%

Trading Range & Key Levels

30-Day Trading Range $0.18 - $0.24
Current vs Trading Range OVERSOLD
Support Level $0.17
Resistance Level $0.21
Current Trend Strong Downtrend
Technical data as of Nov 11, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Strong technical setup (67/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-6.4%)
  • BULLISH: Trading 438.8% below Wall St target ($1.00)
  • WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -0.32
Wall Street Target $1.00 (+438.8%)
Revenue Growth (YoY) -65.8%
Share TCRX Analysis

Share this live TCRX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (TCRX)

Bullish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages indicate a bullish sentiment towards $TCRX, with no recent news articles available.
Key Retail Themes: Trader optimism Lack of news
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:51 PM ET
Data refreshes hourly during market hours. Next update: 2:51 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for TCRX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$302 51 HOLD
VRTX
Vertex Pharmaceuticals I…
STRONG BUY
32 analysts
$592 39 SELL
ONC
BeOne Medicines AG
STRONG BUY
27 analysts
$438 30 SELL
ASND
Ascendis Pharma AS
STRONG BUY
21 analysts
$304 36 SELL
ORIC
Oric Pharmaceuticals Inc
STRONG BUY
15 analysts
$22 67 BUY

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive TCRX Research Pages
TCRX Technical Chart TCRX Price Prediction TCRX Intrinsic Value DCF TCRX Earnings Date TCRX Investment Advisor TCRX Fair Price Analyzer TCRX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals